The Status of Telestroke in the United States: A Survey of Currently Active Stroke Telemedicine Programs

Background and Purpose Little is known about adoption or success of telestroke networks outside of published or federally funded programs. Under contract to the Health Resource Services Administration, we conducted an environmental scan of telestroke programs in the United States. Methods An analyst contacted all potential programs identified in comprehensive online searches, interviewed respondents, and collected response data about structural and functional components of currently operating telestroke programs. Results Among 97 potential programs contacted, 56 programs had confirmed telestroke activity, and 38 programs (68%) from 27 states participated. Hospital and community characteristics of nonparticipating programs were similar to those of participating ones. The top 3 clinical needs met by the telestroke were emergency department consultation (100%), patient triage (83.8%), and inpatient teleconsultation (46.0%). Telestroke programs were in operation a median of 2.44 years (interquartile range, 1.36–3.44 years); 94.6% used 2-way, real-time interactive video plus imaging, but only 44% used dedicated telemedicine consultation software. The mean number of spokes per hub increased significantly from 2007 to 2008 to 2009 (3.78 versus 7.60; P<0.05), and >80% of spoke sites were rural or small hospitals. Reimbursement was absent for >40% of sites. Sites rated inability to obtain physician licensure (27.77%), lack of program funds (27.77%), and lack of reimbursement (19.44%) as the most important barriers to program growth. Conclusions Telestroke is a widespread and growing practice model. Important barriers to expansion amenable to change relate to organizational, technical, and educational domains and external economic and regulatory forces.

[1]  Mary G. George,et al.  Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. , 2009, Stroke.

[2]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[3]  Ajay Bhalla,et al.  Telestroke: a concept in practice. , 2010, Age and ageing.

[4]  T. Ingall,et al.  Stroke telemedicine. , 2009, Mayo Clinic proceedings.

[5]  Alison Bowes,et al.  Effectiveness of telemedicine: A systematic review of reviews , 2010, Int. J. Medical Informatics.

[6]  Peter Sandercock,et al.  A systematic review of barriers to delivery of thrombolysis for acute stroke. , 2004, Age and ageing.

[7]  R. Nelson,et al.  The cost-effectiveness of telestroke in the treatment of acute ischemic stroke , 2011, Neurology.

[8]  Vaibhav Garg,et al.  Telemedicine Security: A Systematic Review , 2011, Journal of diabetes science and technology.

[9]  Robert J Adams,et al.  Telestroke: extending stroke expertise into underserved areas , 2006, The Lancet Neurology.

[10]  S. Levine,et al.  "Telestroke" : the application of telemedicine for stroke. , 1999, Stroke.

[11]  D A Asch,et al.  Response rates to mail surveys published in medical journals. , 1997, Journal of clinical epidemiology.

[12]  I. Couper Rural hospital focus: defining rural. , 2003, Rural and remote health.

[13]  G. Andersen,et al.  Organisational barriers to thrombolysis treatment of acute ischaemic stroke , 2007, Current medical research and opinion.

[14]  Jeffrey L Saver,et al.  Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. , 2009, Stroke.

[15]  Thierry Moulin,et al.  Telemedicine in Stroke: Organizing a Network – Rationale and Baseline Principles , 2009, Cerebrovascular Diseases.

[16]  D. McArthur,et al.  Barriers to telemedicine: survey of current users in acute care units. , 2012, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[17]  B. Demaerschalk,et al.  Cost analysis review of stroke centers, telestroke, and rt-PA. , 2010, The American journal of managed care.

[18]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[19]  S. Pendlebury,et al.  Risk of Recurrent Stroke, Other Vascular Events and Dementia after Transient Ischaemic Attack and Stroke , 2009, Cerebrovascular Diseases.

[20]  C. Wild,et al.  Telemedicine in acute stroke management: Systematic review , 2010, International Journal of Technology Assessment in Health Care.

[21]  Elena V. Khasanshina,et al.  An analysis of business issues in a telestroke project , 2007, Journal of telemedicine and telecare.

[22]  Dawn Kleindorfer,et al.  Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 Years , 2011, Stroke.

[23]  Thierry Moulin,et al.  Barriers, Legal Issues, Limitations and Ongoing Questions in Telemedicine Applied to Stroke , 2009, Cerebrovascular Diseases.

[24]  J. R. Scotti,et al.  Available From , 1973 .

[25]  Brett C Meyer,et al.  A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care: A Scientific Statement From the American Heart Association/American Stroke Association , 2009, Stroke.

[26]  L. Schwamm,et al.  Telestroke: Scientific Results , 2009, Cerebrovascular Diseases.

[27]  B. Demaerschalk,et al.  How Diagnosis-Related Group 559 Will Change the US Medicare Cost Reimbursement Ratio for Stroke Centers , 2007, Stroke.

[28]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .